http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1924316-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24906560716f1a54a24e14a01053c031 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M35-00 |
| filingDate | 2006-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad87f0ddb9bb521a2278b7e1717d8be6 |
| publicationDate | 2008-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1924316-A2 |
| titleOfInvention | Pharmaceutical delivery device and method for providing ocular treatment |
| abstract | Disclosed herein is a novel pharmaceutical delivery device that provides controlled, sustained local delivery of a therapeutic agent of interest to a target tissue of interest, for example, the vitreous tissue of the eye, over an extended period of time. |
| priorityDate | 2005-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 180.